{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:21:44Z","timestamp":1778840504503,"version":"3.51.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:00:00Z","timestamp":1339545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00702-012-0839-2","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T07:59:18Z","timestamp":1340265558000},"page":"103-111","source":"Crossref","is-referenced-by-count":35,"title":["Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"120","author":[{"given":"Lezanne","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldip","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perminder","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"839_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000111082","volume":"25","author":"P Aalten","year":"2008","unstructured":"Aalten P, Verhey FR, Boziki M, Brugnolo A, Bullock R, Byrne EJ, Camus V, Caputo M et al (2008) Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord 25:1\u20138","journal-title":"Dement Geriatr Cogn Disord"},{"key":"839_CR2","doi-asserted-by":"crossref","first-page":"17669","DOI":"10.1371\/journal.pone.0017669","volume":"6","author":"PA Adlard","year":"2011","unstructured":"Adlard PA, Bica L, White AR, Nurjono M, Filiz G, Crouch PJ, Donnelly PS, Cappai R et al (2011) Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer\u2019s disease. PLoS ONE 6:17669","journal-title":"PLoS ONE"},{"key":"839_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T (2009) Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol 118:167\u2013179","journal-title":"Acta Neuropathol"},{"key":"839_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2353\/ajpath.2010.090955","volume":"177","author":"T Arendt","year":"2010","unstructured":"Arendt T, Bruckner MK, Mosch B, Losche A (2010) Selective cell death of hyperploid neurons in Alzheimer\u2019s disease. Am J Pathol 177:15\u201320","journal-title":"Am J Pathol"},{"key":"839_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","volume":"18","author":"SR Bareggi","year":"2012","unstructured":"Bareggi SR, Cornelli U (2012) Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 18:41\u201346","journal-title":"CNS Neurosci Ther"},{"key":"839_CR6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/stem.626","volume":"29","author":"CJ Bissonnette","year":"2011","unstructured":"Bissonnette CJ, Lyass L, Bhattacharyya BJ, Belmadani A, Miller RJ, Kessler JA (2011) The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells 29:802\u2013811","journal-title":"Stem Cells"},{"key":"839_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cell.2010.12.032","volume":"144","author":"C Bock","year":"2011","unstructured":"Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144:439\u2013452","journal-title":"Cell"},{"key":"839_CR8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G et al (1996) Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate A\u03b21-42\/1-40 ratio in vitro and in vivo. Neuron 17:1005\u20131013","journal-title":"Neuron"},{"key":"839_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak H, Del Tredici K (2004) Alzheimer\u2019s disease: intraneuronal alterations precede insoluble amyloid-beta formation. Neurobiol Aging 25:713\u2013718 (discussion 743\u2013716)","journal-title":"Neurobiol Aging"},{"key":"839_CR10","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100\u00a0years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"839_CR11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0197-4580(02)00120-3","volume":"23","author":"AI Bush","year":"2002","unstructured":"Bush AI (2002) Metal complexing agents as therapies for Alzheimer\u2019s disease. Neurobiol Aging 23:1031\u20131038","journal-title":"Neurobiol Aging"},{"key":"839_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2002-4309","volume":"4","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Griffin S, M\u00fcnch G, Pasinetti GM (2002) Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer\u2019s disease brain exists. J Alzheimers Dis 4:193\u2013201","journal-title":"J Alzheimers Dis"},{"key":"839_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2885","volume":"224","author":"RJ Castellani","year":"2011","unstructured":"Castellani RJ, Smith MA (2011) Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is \u2018too big to fail\u2019. J Pathol 224:147\u2013152","journal-title":"J Pathol"},{"key":"839_CR14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt.1580","volume":"27","author":"EM Chan","year":"2009","unstructured":"Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O et al (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27:1033\u20131037","journal-title":"Nat Biotechnol"},{"key":"839_CR15","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.0402338101","volume":"101","author":"F Chen","year":"2004","unstructured":"Chen F, Wollmer MA, Hoerndli F, M\u00fcnch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A et al (2004) Role for glyoxalase I in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101:7687\u20137692","journal-title":"Proc Natl Acad Sci USA"},{"key":"839_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/scd.2010.0440","volume":"21","author":"HC Chung","year":"2012","unstructured":"Chung HC, Lin RC, Logan GJ, Alexander IE, Sachdev PS, Sidhu KS (2012) Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles. Stem Cells Dev 21:206\u2013216","journal-title":"Stem Cells Dev"},{"key":"839_CR17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000095270","volume":"3","author":"E Czirr","year":"2006","unstructured":"Czirr E, Weggen S (2006) Gamma-secretase modulation with A\u03b242-lowering nonsteroidal anti-inflammatory drugs and derived compounds. Neuro-degenerative Dis 3:298\u2013304","journal-title":"Neuro-degenerative Dis"},{"key":"839_CR18","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.2174\/138161206778793001","volume":"12","author":"KA Dasilva","year":"2006","unstructured":"Dasilva KA, Aubert I, McLaurin J (2006) Vaccine development for Alzheimer\u2019s disease. Curr Pharm Des 12:4283\u20134293","journal-title":"Curr Pharm Des"},{"key":"839_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.wneu.2010.12.055","volume":"76","author":"JD Ebben","year":"2011","unstructured":"Ebben JD, Zorniak M, Clark PA, Kuo JS (2011) Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine. World Neurosurg 76:270\u2013275","journal-title":"World Neurosurg"},{"key":"839_CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","volume":"20","author":"NG Faux","year":"2010","unstructured":"Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L et al (2010) PBT2 rapidly improves cognition in Alzheimer\u2019s disease: additional phase II analyses. J Alzheimers Dis 20:509\u2013516","journal-title":"J Alzheimers Dis"},{"key":"839_CR21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/stem.321","volume":"28","author":"Q Feng","year":"2010","unstructured":"Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS et al (2010) Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704\u2013712","journal-title":"Stem Cells"},{"key":"839_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","volume":"690","author":"S Fuller","year":"2010","unstructured":"Fuller S, Steele M, Munch G (2010) Activated astroglia during chronic inflammation in Alzheimer\u2019s disease\u2014do they neglect their neurosupportive roles? Mutat Res 690:40\u201349","journal-title":"Mutat Res"},{"key":"839_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1042\/bst0230080","volume":"23","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Spillantini MG, Crowther RA, Cohen P, Vanmechelen E, Probst A, Gotz J et al (1995a) Tau protein in Alzheimer\u2019s disease. Biochem Soc Trans 23:80\u201385","journal-title":"Biochem Soc Trans"},{"key":"839_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0197-4580(95)00017-9","volume":"16","author":"M Goedert","year":"1995","unstructured":"Goedert M, Spillantini MG, Jakes R, Crowther RA, Vanmechelen E, Probst A, Gotz J, Burki K et al (1995b) Molecular dissection of the paired helical filament. Neurobiol Aging 16:325\u2013334","journal-title":"Neurobiol Aging"},{"key":"839_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","volume":"69","author":"TE Golde","year":"2011","unstructured":"Golde TE, Schneider LS, Koo EH (2011) Anti-A\u03b2 therapeutics in Alzheimer\u2019s disease: the need for a paradigm shift. Neuron 69:203\u2013213","journal-title":"Neuron"},{"key":"839_CR26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000283475","volume":"7","author":"J Gotz","year":"2010","unstructured":"Gotz J, Lim YA, Ke YD, Eckert A, Ittner LM (2010) Dissecting toxicity of tau and beta-amyloid. Neurodegener Dis 7:10\u201312","journal-title":"Neurodegener Dis"},{"key":"839_CR27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","volume":"10","author":"M Grskovic","year":"2011","unstructured":"Grskovic M, Javaherian A, Strulovici B, Daley GQ (2011) Induced pluripotent stem cells\u2014opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10:915\u2013929","journal-title":"Nat Rev Drug Discov"},{"key":"839_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/473272a","volume":"473","author":"EC Hayden","year":"2011","unstructured":"Hayden EC (2011) Stem cells: the growing pains of pluripotency. Nature 473:272\u2013274","journal-title":"Nature"},{"key":"839_CR29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pharmthera.2006.07.001","volume":"113","author":"L Holmquist","year":"2007","unstructured":"Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, M\u00fcnch G (2007) Lipoic acid as a novel treatment for Alzheimer\u2019s disease and related dementias. Pharmacol Ther 113:154\u2013164","journal-title":"Pharmacol Ther"},{"key":"839_CR30","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107:4335\u20134340","journal-title":"Proc Natl Acad Sci USA"},{"key":"839_CR31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/138161206775474251","volume":"12","author":"A Huber","year":"2006","unstructured":"Huber A, Stuchbury G, Burkle A, Burnell J, M\u00fcnch G (2006) Neuroprotective therapies for Alzheimer\u2019s disease. Curr Pharm Des 12:705\u2013717","journal-title":"Curr Pharm Des"},{"key":"839_CR32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802611795860942","volume":"11","author":"BP Imbimbo","year":"2011","unstructured":"Imbimbo BP, Giardina GA (2011) \u03b3-secretase inhibitors and modulators for the treatment of Alzheimer\u2019s disease: disappointments and hopes. Curr Top Med Chem 11:1555\u20131570","journal-title":"Curr Top Med Chem"},{"key":"839_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S et al (2012) Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482:216\u2013220","journal-title":"Nature"},{"key":"839_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45\u201353","journal-title":"Neuron"},{"key":"839_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/WCO.0b013e3283518226","volume":"25","author":"YW Jung","year":"2012","unstructured":"Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH (2012) Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol 25:125\u2013130","journal-title":"Curr Opin Neurol"},{"key":"839_CR36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698\u2013712","journal-title":"Nat Rev Drug Discov"},{"key":"839_CR37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.exger.2010.03.001","volume":"45","author":"M Krautwald","year":"2010","unstructured":"Krautwald M, M\u00fcnch G (2010) Advanced glycation end products as biomarkers and gerontotoxins\u2014a basis to explore methylglyoxal-lowering agents for Alzheimer\u2019s disease? Exp Gerontol 45:744\u2013751","journal-title":"Exp Gerontol"},{"key":"839_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00702-003-0038-2","volume":"111","author":"B Kuhla","year":"2004","unstructured":"Kuhla B, Loske C, Garcia De Arriba S, Schinzel R, Huber J, M\u00fcnch G (2004) Differential effects of \u201cAdvanced glycation endproducts\u201d and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y. J Neural Transm 111:427\u2013439","journal-title":"J Neural Transm"},{"key":"839_CR39","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1074\/jbc.M609521200","volume":"282","author":"B Kuhla","year":"2007","unstructured":"Kuhla B, Haase C, Flach K, Luth HJ, Arendt T, M\u00fcnch G (2007) Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem 282:6984\u20136991","journal-title":"J Biol Chem"},{"key":"839_CR40","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1046\/j.1432-1327.2000.01452.x","volume":"267","author":"C Loske","year":"2000","unstructured":"Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, M\u00fcnch G (2000) Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem 267:4171\u20134178","journal-title":"Eur J Biochem"},{"key":"839_CR41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1433.026","volume":"1126","author":"A Maczurek","year":"2008","unstructured":"Maczurek A, Shanmugam K, Munch G (2008) Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer\u2019s disease. Ann NY Acad Sci 1126:147\u2013151","journal-title":"Ann NY Acad Sci"},{"key":"839_CR42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrneurol.2011.144","volume":"7","author":"K Malpass","year":"2011","unstructured":"Malpass K (2011) Parkinson disease: induced pluripotent stem cells\u2014a new in vitro model to investigate alpha-synuclein dysfunction in Parkinson disease. Nat Rev Neurol 7:536","journal-title":"Nat Rev Neurol"},{"key":"839_CR43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s007020200091","volume":"109","author":"G M\u00fcnch","year":"2002","unstructured":"M\u00fcnch G, Robinson SR (2002) Potential neurotoxic inflammatory responses to A\u03b2 vaccination in humans. J Neural Transm 109:1081\u20131087","journal-title":"J Neural Transm"},{"key":"839_CR44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-0173(96)00016-1","volume":"23","author":"G M\u00fcnch","year":"1997","unstructured":"M\u00fcnch G, Thome J, Foley P, Schinzel R, Riederer P (1997) Advanced glycation endproducts in ageing and Alzheimer\u2019s disease. Brain Res Brain Res Rev 23:134\u2013143","journal-title":"Brain Res Brain Res Rev"},{"key":"839_CR45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s007020050069","volume":"105","author":"G M\u00fcnch","year":"1998","unstructured":"M\u00fcnch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA et al (1998) Alzheimer\u2019s disease\u2014synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105:439\u2013461","journal-title":"J Neural Transm"},{"key":"839_CR46","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1634\/stemcells.2008-0074","volume":"26","author":"W Murrell","year":"2008","unstructured":"Murrell W, Wetzig A, Donnellan M, Feron F, Burne T, Meedeniya A, Kesby J, Bianco J et al (2008) Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson\u2019s disease. Stem Cells 26:2183\u20132192","journal-title":"Stem Cells"},{"key":"839_CR47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/156720511796717122","volume":"8","author":"LP Navarrete","year":"2011","unstructured":"Navarrete LP, Perez P, Morales I, Maccioni RB (2011) Novel drugs affecting tau behavior in the treatment of Alzheimer\u2019s disease and tauopathies. Curr Alzheimer Res 8:678\u2013685","journal-title":"Curr Alzheimer Res"},{"key":"839_CR48","doi-asserted-by":"crossref","first-page":"e1002085","DOI":"10.1371\/journal.pgen.1002085","volume":"7","author":"K Nishino","year":"2011","unstructured":"Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A (2011) DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 7:e1002085","journal-title":"PLoS Genet"},{"key":"839_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-60761-962-8_4","volume":"690","author":"MD O\u2019Connor","year":"2011","unstructured":"O\u2019Connor MD, Kardel MD, Eaves CJ (2011) Functional assays for human embryonic stem cell pluripotency. Methods Mol Biol 690:67\u201380","journal-title":"Methods Mol Biol"},{"key":"839_CR50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313\u2013317","journal-title":"Nature"},{"key":"839_CR51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg2100","volume":"8","author":"L Ooi","year":"2007","unstructured":"Ooi L, Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8:544\u2013554","journal-title":"Nat Rev Genet"},{"key":"839_CR52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2217\/imt.10.80","volume":"2","author":"F Panza","year":"2010","unstructured":"Panza F, Frisardi V, Imbimbo BP, D\u2019Onofrio G, Pietrarossa G, Seripa D, Pilotto A, Solfrizzi V (2010) Bapineuzumab: anti-beta-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. Immunotherapy 2:767\u2013782","journal-title":"Immunotherapy"},{"key":"839_CR53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C et al (2008) Disease-specific induced pluripotent stem cells. Cell 134:877\u2013886","journal-title":"Cell"},{"key":"839_CR54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cell.2011.07.007","volume":"146","author":"L Qiang","year":"2011","unstructured":"Qiang L, Fujita R, Yamashita T, Angulo S, Rhinn H, Rhee D, Doege C, Chau L et al (2011) Directed conversion of Alzheimer\u2019s disease patient skin fibroblasts into functional neurons. Cell 146:359\u2013371","journal-title":"Cell"},{"key":"839_CR55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/CCLM.2011.079","volume":"49","author":"A Rahmadi","year":"2011","unstructured":"Rahmadi A, Steiner N, M\u00fcnch G (2011) Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer\u2019s disease. Clin Chem Lab Med 49:385\u2013391","journal-title":"Clin Chem Lab Med"},{"key":"839_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-7091-7508-8_22","volume":"54","author":"W Retz","year":"1998","unstructured":"Retz W, Gsell W, M\u00fcnch G, Rosler M, Riederer P (1998) Free radicals in Alzheimer\u2019s disease. J Neural Transm Suppl 54:221\u2013236","journal-title":"J Neural Transm Suppl"},{"key":"839_CR57","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00702-006-0591-6","volume":"113","author":"P Riederer","year":"2006","unstructured":"Riederer P, Hoyer S (2006) From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm 113:1671\u20131677","journal-title":"J Neural Transm"},{"key":"839_CR58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neurobiolaging.2003.12.020","volume":"25","author":"SR Robinson","year":"2004","unstructured":"Robinson SR, Bishop GM, Lee HG, M\u00fcnch G (2004) Lessons from the AN 1792 Alzheimer vaccine: lest we forget. Neurobiol Aging 25:609\u2013615","journal-title":"Neurobiol Aging"},{"key":"839_CR59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. Int J Dev Neurosci 24:167\u2013176","journal-title":"Int J Dev Neurosci"},{"key":"839_CR60","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870","journal-title":"Nat Med"},{"key":"839_CR61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563","journal-title":"Behav Brain Res"},{"key":"839_CR62","doi-asserted-by":"crossref","unstructured":"Shi Y, Kirwan P, Smith J, MacLean G, Orkin SH, Livesey FJ (2012) A human stem cell model of early Alzheimer\u2019s disease pathology in Down syndrome. Sci Transl Med 4:124ra129.","DOI":"10.1126\/scitranslmed.3003771"},{"key":"839_CR63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/14712598.2011.558837","volume":"11","author":"KS Sidhu","year":"2011","unstructured":"Sidhu KS (2011) New approaches for the generation of induced pluripotent stem cells. Expert Opin Biol Ther 11:569\u2013579","journal-title":"Expert Opin Biol Ther"},{"key":"839_CR64","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(10)61994-0","volume":"376","author":"AD Smith","year":"2010","unstructured":"Smith AD (2010) Why are drug trials in Alzheimer\u2019s disease failing? Lancet 376:1466","journal-title":"Lancet"},{"key":"839_CR65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","volume":"61","author":"F Song","year":"2009","unstructured":"Song F, Poljak A, Smythe GA, Sachdev P (2009) Plasma biomarkers for mild cognitive impairment and Alzheimer\u2019s disease. Brain Res Rev 61:69\u201380","journal-title":"Brain Res Rev"},{"key":"839_CR66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","volume":"32","author":"V Srikanth","year":"2011","unstructured":"Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, M\u00fcnch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease. Neurobiol Aging 32:763\u2013777","journal-title":"Neurobiol Aging"},{"key":"839_CR67","doi-asserted-by":"crossref","first-page":"15720","DOI":"10.1073\/pnas.0908450106","volume":"106","author":"N Sun","year":"2009","unstructured":"Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM et al (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106:15720\u201315725","journal-title":"Proc Natl Acad Sci USA"},{"key":"839_CR68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"839_CR69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"},{"key":"839_CR70","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"839_CR71","doi-asserted-by":"crossref","unstructured":"Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ 2006:re1.","DOI":"10.1126\/sageke.2006.6.re1"},{"key":"839_CR72","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s001150050073","volume":"67","author":"J Thome","year":"1996","unstructured":"Thome J, Kornhuber J, M\u00fcnch G, Schinzel R, Taneli Y, Zielke B, Rosler M, Riederer P (1996) New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs). Nervenarzt 67:924\u2013929","journal-title":"Nervenarzt"},{"key":"839_CR73","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1073\/pnas.94.5.2025","volume":"94","author":"T Tomita","year":"1997","unstructured":"Tomita T, Maruyama K, Saido TC, Kume H, Shinozaki K, Tokuhiro S, Capell A, Walter J et al (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci USA 94:2025\u20132030","journal-title":"Proc Natl Acad Sci USA"},{"key":"839_CR74","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/scd.2008.0008","volume":"17","author":"MJ Valenzuela","year":"2008","unstructured":"Valenzuela MJ, Dean SK, Sachdev P, Tuch BE, Sidhu KS (2008) Neural precursors from canine skin: a new direction for testing autologous cell replacement in the brain. Stem Cells Dev 17:1087\u20131094","journal-title":"Stem Cells Dev"},{"key":"839_CR75","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/stem.199","volume":"27","author":"L Vallier","year":"2009","unstructured":"Vallier L, Touboul T, Brown S, Cho C, Bilican B, Alexander M, Cedervall J, Chandran S et al (2009a) Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 27:2655\u20132666","journal-title":"Stem Cells"},{"key":"839_CR76","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1371\/journal.pone.0006082","volume":"4","author":"L Vallier","year":"2009","unstructured":"Vallier L, Touboul T, Chng Z, Brimpari M, Hannan N, Millan E, Smithers LE, Trotter M et al (2009b) Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS ONE 4:6082","journal-title":"PLoS ONE"},{"key":"839_CR77","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035\u20131041","journal-title":"Nature"},{"key":"839_CR78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1752-8062.2009.00121.x","volume":"2","author":"HI Wan","year":"2009","unstructured":"Wan HI, Jacobsen JS, Rutkowski JL, Feuerstein GZ (2009) Translational medicine lessons from flurizan\u2019s failure in Alzheimer\u2019s disease (AD) trial: implication for future drug discovery and development for AD. Clin Transl Sci 2:242\u2013247","journal-title":"Clin Transl Sci"},{"key":"839_CR79","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1089\/scd.2010.0574","volume":"20","author":"A Wang","year":"2011","unstructured":"Wang A, Huang K, Shen Y, Xue Z, Cai C, Horvath S, Fan G (2011) Functional modules distinguish human induced pluripotent stem cells from embryonic stem cells. Stem Cells Dev 20:1937\u20131950","journal-title":"Stem Cells Dev"},{"key":"839_CR80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0083-6729(06)74020-1","volume":"74","author":"D Weisman","year":"2006","unstructured":"Weisman D, Hakimian E, Ho GJ (2006) Interleukins, inflammation, and mechanisms of Alzheimer\u2019s disease. Vitam Horm 74:505\u2013530","journal-title":"Vitam Horm"},{"key":"839_CR81","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","volume":"448","author":"M Wernig","year":"2007","unstructured":"Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318\u2013324","journal-title":"Nature"},{"key":"839_CR82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(01)02872-4","volume":"920","author":"A Wong","year":"2001","unstructured":"Wong A, Luth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, M\u00fcnch G (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer\u2019s disease. Brain Res 920:32\u201340","journal-title":"Brain Res"},{"key":"839_CR83","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H et al (2011) Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet 20:4530\u20134539","journal-title":"Hum Mol Genet"},{"key":"839_CR84","doi-asserted-by":"crossref","first-page":"e25788","DOI":"10.1371\/journal.pone.0025788","volume":"6","author":"N Yahata","year":"2011","unstructured":"Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K et al (2011) Anti-A\u03b2 drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer\u2019s disease. PLoS ONE 6:e25788","journal-title":"PLoS ONE"},{"key":"839_CR85","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920","journal-title":"Science"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0839-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0839-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0839-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T01:03:14Z","timestamp":1561856594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0839-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0839-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]}}}